With the analysis among 611 patents, we discovered top 152 key players by total patent application. Bristol Myers Squibb Co., Vertex Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd. are dominant in this area. They take 18.82% of the total patent filing.
New York, United States
Patent: 54
Vertex Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 37
F. Hoffmann-La Roche Ltd.
ViiV Healthcare UK (No. 4) Ltd.
Hessen, Germany
Patent: 18
Antwerpen, Belgium
Patent: 16
Brussels Hoofdstedelijk Gewest, Belgium
Patent: 14
undefined undefined
Patent: 13
Queensland, Australia
Patent: 12
Nanjing Mingde New Drug Research and Development Co., Ltd.
Jiangsu Sheng, China
Patent: 12
With the analysis among 11 patents, we discovered top 6 start-ups by total patent application. Enliven Therapeutics, Inc. /US/, Institut National de la Santé et de la Recherche Médicale, Leto Laboratories Co., Ltd. are active in this area.
Enliven Therapeutics, Inc. /US/
Colorado, United States
Patent: 5
Institut National de la Santé et de la Recherche Médicale
Leto Laboratories Co., Ltd.
Beijing Shi, China
Patent: 1
Shanghai KeChow Pharmaceuticals Co., Ltd.
Shanghai Shi, China
Patent: 1
Massachusetts, United States
Patent: 1
Buckinghamshire, United Kingdom
Patent: 1
With the analysis among related 279 patents applied in the last 5 years. We discover 101 most active companies in this area. The fast-growing Bristol Myers Squibb Co., UCB SA, Nanjing Mingde New Drug Research and Development Co., Ltd. take 24.37% of patent filing during this period.
New York, United States
Patent: 42
Brussels Hoofdstedelijk Gewest, Belgium
Patent: 14
Nanjing Mingde New Drug Research and Development Co., Ltd.
Jiangsu Sheng, China
Patent: 12
Regents of the University of California
California, United States
Patent: 11
Jiangsu Vcare PharmaTech Co., Ltd.
Jiangsu Sheng, China
Patent: 9
Antwerpen, Belgium
Patent: 9
Dana-Farber Cancer Institute, Inc.
Massachusetts, United States
Patent: 9
Global Blood Therapeutics, Inc.
California, United States
Patent: 8
Intervet International BV
Noord-Brabant, Netherlands
Patent: 7
With the analysis among related 279 patents in last 5 years, we discover 86 new entrants. UCB SA, Nanjing Mingde New Drug Research and Development Co., Ltd., Regents of the University of California are the most active new entrants in this area.
Brussels Hoofdstedelijk Gewest, Belgium
Patent: 14
Nanjing Mingde New Drug Research and Development Co., Ltd.
Jiangsu Sheng, China
Patent: 12
Regents of the University of California
California, United States
Patent: 11
Jiangsu Vcare PharmaTech Co., Ltd.
Jiangsu Sheng, China
Patent: 9
Dana-Farber Cancer Institute, Inc.
Massachusetts, United States
Patent: 9
Global Blood Therapeutics, Inc.
California, United States
Patent: 8
Aichi-ken, Japan
Patent: 7
Centre National De La Recherche Scientif
Enliven Therapeutics, Inc. /US/
Colorado, United States
Patent: 5
With the analysis among 68 patents, we discovered top 31 universities and scientific research institutions by total patent application. The Johannes Gutenberg University of Mainz, Fudan University, Shaanxi University of Science & Technology are dominant in this area. They take 32.35% of the total patent filing.
The Johannes Gutenberg University of Mainz
Rheinland-Pfalz, Germany
Patent: 5
Shanghai Shi, China
Patent: 3
Shaanxi University of Science & Technology
Shaanxi Sheng, China
Patent: 3
Zhejiang Sheng, China
Patent: 2
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 2
Washington, United States
Patent: 2
Jiangsu University of Technology
Jiangsu Sheng, China
Patent: 2
Zhejiang Sheng, China
Patent: 2
Case Western Reserve University
Ohio, United States
Patent: 1
The European Molecular Biology Laboratory
Baden-Württemberg, Germany
Patent: 1